Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 1.00 is 98% below its estimated 5-year average of 42.80, near the low end of its estimated 5-year range (0.86–302.99).
As of 2026-10-06T15:42:56.633Z. 71.82% below its estimated 12-month average of 3.55.
Calculation as of: 2026-10-06T15:42:56.633Z.
Quote observation: 2026-10-06T15:39:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 16c1118283d3d380e79e54cd720e88a66b4293c4936e446a72c17353f5d031e1
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
1.00
PS RATIO AVG TTM
3.55
PS RATIO AVG 3Y
5.33
PS RATIO AVG 5Y
42.80
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-71.82%
CURRENT VS 3Y AVG
-81.23%
CURRENT VS 5Y AVG
-97.66%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.17
median of 471 covered companies
CURRENT VS SECTOR MEDIAN
-76.02%
vs the sector median at left
NeuroOne Medical Technologies Corporation
Market Cap
$10.01M
PS Ratio
1.00
TTM Avg
3.55
3Y Avg
5.33
5Y Avg
42.80
Market Cap
$10.36M
PS Ratio
8934.76
TTM Avg
9868.69
3Y Avg
9868.69
5Y Avg
9868.69
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeuroOne Medical Technologies Corporation (NMTC) | $10.01M | 1.00 | 3.55 | 5.33 | 42.80 |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.08M | N/A | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.80M | 720.26 | 337.84 | 351.63 | 923.89 |
| MetaVia Inc. (MTVA)vs › | $9.68M | N/A | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.36M | 8934.76 | 9868.69 | 9868.69 | 9868.69 |
| Satellos Bioscience Inc. (MSLE)vs › | $10.47M | N/A | N/A | N/A | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.53M | N/A | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.57M | 0.48 | 0.51 | 1.36 | 4.08 |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.29M | N/A | N/A | N/A | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.77M | N/A | 32.91 | 62.07 | 66.46 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-09-30 | $2,740,925 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-12-17 |
| Q1 FY2026Period ended 2025-12-31 | $2,892,635 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-17 |
| Q2 FY2026Period ended 2026-03-31 | $2,391,185 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-12 |
| Q3 FY2026Period ended 2026-06-30 | $1,973,105 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $9,997,850 |
Current P/S: $10,008,429 market capitalization ÷ $9,997,850 TTM revenue = 1.00x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:39:12.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
At 1.00, P/S is below its estimated 6-year median — higher than 0% of readings in its estimated 6-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 6-year low
0.86
median
13.74
estimated 6-year high
302.99
P/S Ratio
1.00
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 0.98 |
| 2026-10-02 | 0.98 |
| 2026-10-01 | 0.86 |
| 2026-09-30 | 0.90 |
| 2026-09-29 | 0.95 |
| 2026-09-28 | 1.14 |
| 2026-09-25 | 1.16 |
| 2026-09-24 | 1.16 |
| 2026-09-23 | 1.17 |
| 2026-09-22 | 1.21 |
| 2026-09-21 | 1.14 |
| 2026-09-18 | 1.22 |
| 2026-09-17 | 1.19 |
| 2026-09-16 | 1.23 |
| 2026-09-15 | 1.28 |
| 2026-09-14 | 1.31 |
| 2026-09-11 | 1.36 |
| 2026-09-10 | 1.38 |
| 2026-09-09 | 1.45 |
| 2026-09-08 | 1.48 |
| 2026-09-04 | 1.42 |
| 2026-09-03 | 1.45 |
| 2026-09-02 | 1.46 |
| 2026-09-01 | 1.41 |
| 2026-08-31 | 1.49 |
| 2026-08-28 | 1.55 |
| 2026-08-27 | 1.73 |
| 2026-08-26 | 1.75 |
| 2026-08-25 | 1.89 |
| 2026-08-24 | 1.87 |
| 2026-08-21 | 1.77 |
| 2026-08-20 | 1.88 |
| 2026-08-19 | 1.91 |
| 2026-08-18 | 1.64 |
| 2026-08-17 | 1.64 |
| 2026-08-14 | 1.70 |
| 2026-08-13 | 1.61 |
| 2026-08-12 | 1.34 |
| 2026-08-11 | 1.41 |
| 2026-08-10 | 1.37 |
| 2026-08-07 | 1.43 |
| 2026-08-06 | 1.36 |
| 2026-08-05 | 1.45 |
| 2026-08-04 | 1.49 |
| 2026-08-03 | 1.50 |
| 2026-07-31 | 1.49 |
| 2026-07-30 | 1.50 |
| 2026-07-29 | 1.45 |
| 2026-07-28 | 1.47 |
| 2026-07-27 | 1.55 |
| 2026-07-24 | 1.67 |
| 2026-07-23 | 1.63 |
| 2026-07-22 | 1.70 |
| 2026-07-21 | 1.80 |
| 2026-07-20 | 1.90 |
| 2026-07-17 | 2.06 |
| 2026-07-16 | 2.09 |
| 2026-07-15 | 2.21 |
| 2026-07-14 | 2.14 |
| 2026-07-13 | 2.34 |
| 2026-07-10 | 2.53 |
| 2026-07-09 | 2.42 |
| 2026-07-08 | 2.63 |
| 2026-07-07 | 2.66 |
| 2026-07-06 | 2.72 |
| 2026-07-02 | 2.64 |
| 2026-07-01 | 2.64 |
| 2026-06-30 | 2.68 |
| 2026-06-29 | 2.94 |
| 2026-06-26 | 2.94 |
| 2026-06-25 | 2.82 |
| 2026-06-24 | 2.88 |
| 2026-06-23 | 2.95 |
| 2026-06-22 | 2.86 |
| 2026-06-18 | 2.90 |
| 2026-06-17 | 2.91 |
| 2026-06-16 | 2.86 |
| 2026-06-15 | 2.92 |
| 2026-06-12 | 2.85 |
| 2026-06-11 | 2.85 |
| 2026-06-10 | 2.92 |
| 2026-06-09 | 2.98 |
| 2026-06-08 | 3.04 |
| 2026-06-05 | 3.03 |
| 2026-06-04 | 3.06 |
| 2026-06-03 | 3.05 |
| 2026-06-02 | 3.13 |
| 2026-06-01 | 3.27 |
| 2026-05-29 | 3.12 |
| 2026-05-28 | 3.27 |
| 2026-05-27 | 3.28 |
| 2026-05-26 | 3.41 |
| 2026-05-22 | 3.25 |
| 2026-05-21 | 3.43 |
| 2026-05-20 | 3.60 |
| 2026-05-19 | 3.62 |
| 2026-05-18 | 3.99 |
| 2026-05-15 | 3.70 |
| 2026-05-14 | 4.05 |
| 2026-05-13 | 3.97 |
| 2026-05-12 | 4.22 |
| 2026-05-11 | 4.17 |
| 2026-05-08 | 4.58 |
| 2026-05-07 | 4.37 |
| 2026-05-06 | 4.14 |
| 2026-05-05 | 4.26 |
| 2026-05-04 | 4.32 |
| 2026-05-01 | 4.19 |
| 2026-04-30 | 4.52 |
| 2026-04-29 | 4.52 |
| 2026-04-28 | 4.57 |
| 2026-04-27 | 4.44 |
| 2026-04-24 | 4.58 |
| 2026-04-23 | 4.57 |
| 2026-04-22 | 4.92 |
| 2026-04-21 | 4.86 |
| 2026-04-20 | 4.79 |
| 2026-04-17 | 4.66 |
| 2026-04-16 | 4.40 |
| 2026-04-15 | 4.27 |
| 2026-04-14 | 4.22 |
| 2026-04-13 | 4.33 |
| 2026-04-10 | 4.22 |
| 2026-04-09 | 4.26 |
| 2026-04-08 | 4.16 |
| 2026-04-07 | 4.79 |
| 2026-04-06 | 4.79 |
| 2026-04-02 | 4.59 |
| 2026-04-01 | 4.63 |
| 2026-03-31 | 4.48 |
| 2026-03-30 | 4.29 |
| 2026-03-27 | 4.23 |
| 2026-03-26 | 4.39 |
| 2026-03-25 | 4.45 |
| 2026-03-24 | 4.39 |
| 2026-03-23 | 4.45 |
| 2026-03-20 | 4.50 |
| 2026-03-19 | 4.19 |
| 2026-03-18 | 4.27 |
| 2026-03-17 | 4.22 |
| 2026-03-16 | 4.16 |
| 2026-03-13 | 4.34 |
| 2026-03-12 | 4.55 |
| 2026-03-11 | 4.56 |
| 2026-03-10 | 4.58 |
| 2026-03-09 | 4.55 |
| 2026-03-06 | 4.87 |
| 2026-03-05 | 4.81 |
| 2026-03-04 | 4.56 |
| 2026-03-03 | 4.68 |
| 2026-03-02 | 3.85 |
| 2026-02-27 | 3.87 |
| 2026-02-26 | 3.98 |
| 2026-02-25 | 3.98 |
| 2026-02-24 | 4.02 |
| 2026-02-23 | 3.93 |
| 2026-02-20 | 3.93 |
| 2026-02-19 | 4.09 |
| 2026-02-18 | 3.93 |
| 2026-02-17 | 2.99 |
| 2026-02-13 | 3.59 |
| 2026-02-12 | 3.32 |
| 2026-02-11 | 3.62 |
| 2026-02-10 | 3.54 |
| 2026-02-09 | 3.57 |
| 2026-02-06 | 3.44 |
| 2026-02-05 | 3.24 |
| 2026-02-04 | 3.54 |
| 2026-02-03 | 3.80 |
| 2026-02-02 | 3.69 |
| 2026-01-30 | 3.91 |
| 2026-01-29 | 3.84 |
| 2026-01-28 | 4.00 |
| 2026-01-27 | 3.97 |
| 2026-01-26 | 3.92 |
| 2026-01-23 | 3.80 |
| 2026-01-22 | 3.83 |
| 2026-01-21 | 3.99 |
| 2026-01-20 | 3.97 |
| 2026-01-16 | 3.99 |
| 2026-01-15 | 3.96 |
| 2026-01-14 | 3.84 |
| 2026-01-13 | 3.94 |
| 2026-01-12 | 3.94 |
| 2026-01-09 | 3.87 |
| 2026-01-08 | 3.94 |
| 2026-01-07 | 3.97 |
| 2026-01-06 | 4.33 |
| 2026-01-05 | 3.74 |
| 2026-01-02 | 3.76 |
| 2025-12-31 | 3.35 |
| 2025-12-30 | 3.19 |
| 2025-12-29 | 3.20 |
| 2025-12-26 | 3.22 |
| 2025-12-24 | 3.38 |
| 2025-12-23 | 3.16 |
| 2025-12-22 | 3.55 |
| 2025-12-19 | 3.24 |
| 2025-12-18 | 3.16 |
| 2025-12-17 | 2.95 |
| 2025-12-16 | 5.18 |
| 2025-12-15 | 4.85 |
| 2025-12-12 | 4.81 |
| 2025-12-11 | 4.29 |
| 2025-12-10 | 4.40 |
| 2025-12-09 | 4.59 |
| 2025-12-08 | 4.80 |
| 2025-12-05 | 5.22 |
| 2025-12-04 | 4.92 |
| 2025-12-03 | 5.00 |
| 2025-12-02 | 4.85 |
| 2025-12-01 | 5.00 |
| 2025-11-28 | 5.10 |
| 2025-11-26 | 5.13 |
| 2025-11-25 | 5.01 |
| 2025-11-24 | 4.88 |
| 2025-11-21 | 4.67 |
| 2025-11-20 | 4.41 |
| 2025-11-19 | 4.62 |
| 2025-11-18 | 4.69 |
| 2025-11-17 | 4.96 |
| 2025-11-14 | 5.06 |
| 2025-11-13 | 4.97 |
| 2025-11-12 | 5.38 |
| 2025-11-11 | 5.36 |
| 2025-11-10 | 5.18 |
| 2025-11-07 | 5.10 |
| 2025-11-06 | 5.27 |
| 2025-11-05 | 5.36 |
| 2025-11-04 | 5.30 |
| 2025-11-03 | 5.60 |
| 2025-10-31 | 5.80 |
| 2025-10-30 | 5.80 |
| 2025-10-29 | 5.76 |
| 2025-10-28 | 5.99 |
| 2025-10-27 | 6.12 |
| 2025-10-24 | 5.98 |
| 2025-10-23 | 5.83 |
| 2025-10-22 | 5.65 |
| 2025-10-21 | 6.01 |
| 2025-10-20 | 6.09 |
| 2025-10-17 | 6.05 |
| 2025-10-16 | 6.33 |
| 2025-10-15 | 6.60 |
| 2025-10-14 | 6.65 |
| 2025-10-13 | 6.60 |
| 2025-10-10 | 6.97 |
| 2025-10-09 | 7.55 |
| 2025-10-08 | 7.63 |
| 2025-10-07 | 7.77 |
| 2025-10-06 | 7.30 |
| 2025-10-03 | 6.82 |
| 2025-10-02 | 6.60 |
| 2025-10-01 | 6.53 |
| 2025-09-30 | 6.51 |
| 2025-09-29 | 6.60 |
| 2025-09-26 | 6.73 |
| 2025-09-25 | 6.59 |
| 2025-09-24 | 6.89 |
| 2025-09-23 | 6.92 |
Showing the most recent 260 of 1,461 data points. The chart above shows the full history.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
